The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Editorial
PreviousPrevious
Volume 353:839-841 August 25, 2005 Number 8
NextNext

Angiogenic Pathways in Diabetic Retinopathy
Lloyd Paul Aiello, M.D., Ph.D.

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
 by Watanabe, D.
-PubMed Citation
Visual loss is often considered the most feared complication of human disease, other than death. In 2002, 124 million people worldwide had poor vision and 37 million were blind.1 In developed countries, the primary causes of visual loss are age-related macular degeneration, in the elderly, and diabetic retinopathy, in working-age persons. It is estimated that diabetes mellitus affects 4 percent of the world's population, almost half of whom have some degree of diabetic retinopathy at any given time. Visual loss primarily occurs from either proliferation of new retinal vessels (proliferative diabetic retinopathy) or increased permeability of retinal vessels (diabetic macular . . . [Full Text of this Article]


Source Information

From the Beetham Eye Institute and Eye Research Section, Joslin Diabetes Center, and the Department of Ophthalmology, Harvard Medical School — both in Boston.


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.